12,141 followers
RT @FrontOncology: New research: Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma…
RT @FrontOncology: New research: Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma…
New research: Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review: Pulmonary sarcomatoid carcinoma (PSC) is an uncommon variant of non-small cell lung… https://t.co